3,4-Diaminopyridine in demyelinating peripheral neuropathies
β Scribed by Ryuji Tamura; Yukio Mano; Tetsuya Takayanagi; Richard F. Mayer
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 130 KB
- Volume
- 36
- Category
- Article
- ISSN
- 0364-5134
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
It has been demonstrated that abnormal levels of PMP22 expression due to altered gene dosage in CMT1A neuropathy alters Schwann cell growth and differentiation. On the other hand, disease-related missense mutations within transmembrane domains of PMP22 disturb intracellular protein trafficking leadi
## Mutations in the major peripheral myelin protein zero (PO) gene on chromosome lq21-q23 have been found with the hereditary demyelinating polyneuropathy Charcot-Marie-Tooth type 1B. Here, we describe 2 patients with distinct neurological characteristics, carrying different substitutions at the s